|
|
MUSC Psychiatry Chair Update
Thomas W. Uhde, M.D.
Department of Psychiatry and Behavioral Sciences
Institute of Psychiatry |
|
|---|
|
ONGOING STUDIES & PUBLICATIONS |
|
| |
|
Tobacco Control Advocates Encouraged by FDA Announcement to Ban Menthol Cigarettes |
|
|---|
|
A late-April announcement that the Food and Drug Administration is moving to ban menthol cigarettes and flavored cigars in the United States is sparking hope for tobacco control and smoking-cessation advocates. Michael Cummings, Ph.D., a professor in the Department of Psychiatry and Behavioral Sciences, researcher at MUSC Hollings Cancer Center and a tobacco control expert, believes it is a step in the right direction.
Cummings said the FDA decision could reduce the number of people being introduced to nicotine. Menthol-based products appeal to younger people and minorities due to targeted marketing and flavoring. Cummings believes menthol-based products could be more addictive then regular cigarettes because of the anesthetic effect they have on the airways.
“When you breathe in menthol cigarette smoke, it cools the airways, so it gives a less harsh impression,” he said. “You can make the argument that it’s actually facilitating nicotine addiction because getting the nicotine out of the smoke and into the lungs is critical to the rapid uptake in nicotine, where it has its effect in the brain.”
Cummings has worked to restrict tobacco and reduce addiction for decades. He said menthol-based products are much more widely used in the United States than in Canada and European Union, both of which have undergone bans. |
|
|---|
|
Dr. Rochelle Hanson from the National Crime Victims Research and Treatment Center (NCVC) was also awared a five-year, 3 million dollar federal grant from SAMHSA, National Child Traumatic Stress Network Category II to establish a new Center as a part of the National Child Traumatic Stress Network designed to increase access to evidence-based interventions for children and families who have experienced traumatic events. |
|
|
|
|
For anyone who is requesting promotion effective July 1, 2022, all promotion requests must be received in the Chair’s Office no later than August 12, 2021 in the form of complete packets accompanied by a letter of recommendation from your Division Director. Packets with checklists, requests for materials, and forms specific for regular and modified faculty have been developed to make the submission process more straightforward. Packets are available on the College of Medicine’s website. Follow this link: https://horseshoe.musc.edu/university/colleges/com/faculty/apt-committee/promotion-tenure-forms
Promotion to Associate Professor or Professor requires a minimum of four letters of recommendation, addressed to the Departmental Chair. Individuals selected to write the minimum four letters should be non-MUSC faculty in the candidate’s field at the academic rank of professor or its equivalent stature. At least two of these individuals should not be associated with the candidate by having been past mentors/teachers/students/trainees. We ask that you provide 4-6 names of individuals that we can contact to solicit letters of recommendation.
The letter of recommendation from your Division Director must follow appendix 2 in the COM APT guidelines. Division Director letters should include the following paragraphs: introductory, education, research if applicable, scholarly publications, clinical practice if applicable, administration, and other activities and accomplishments.
If you have any questions, please contact Kristen Mulholland at mulhollk@musc.edu.
|
|
FACULTY ANNUAL LEAVE CUTBACK |
|
MUSC Executive Leadership has extended the Faculty Annual Leave cutback date to December 31, 2021. Based on the December 31 faculty cut back extension, all unused annual leave in excess of 360 hours, regardless of future leave approvals in the kronos system, will be cutback to 360 hours in January 2022.
We encourage you to review the annual leave balances for the faculty members in your areas and determine if you have individuals who stand to lose leave when the automatic reduction occurs, and if so, we ask that you share this information with them. We also ask that you update all leave records as necessary to ensure we have the correct leave balances on file before the automatic reduction occurs. Leave balances can be viewed directly using MyRecords, found on the Horseshoe under the Employee Corner, http://horseshoe.musc.edu/human-resources/univ/employee-corner.
If you have questions concerning annual leave cutbacks or accruals, please contact Monique Robinson at robinsmo@musc.edu or 843-792-7225.
Supervisors are asked to distribute this information to the employees in the area in which they are responsible. Thank you. |
|
TRUSTS KLINGENSTEIN THIRD GENERATION FOUNDATION FELLOWSHIP PROGRAM |
|
MUSC Pre-Application Deadline: July 30, 2021
Fellowship Online Portal Open: Sep 01, 2021
Fellowship Nomination Deadline: Nov 30, 2021
Fellowship Application Deadline: Jan 10, 2022 (by invitation only)
The Klingenstein Third Generation Foundation awards research grants to post-doctoral investigators at esteemed American medical institutions. The Foundation makes up to five fellowship grants to medical institutions that have nominated research projects led by outstanding post-doctoral candidates. The Foundation considers proposals for research projects in the field of child and adolescent ADHD, child and adolescent depression and access to care.
Candidates must hold a Ph.D. and/or M.D. and have completed all clinical training. Candidates should be at the junior faculty level or on a trajectory for attaining faculty status.
Investigators who have K awards or have applied for K awards are eligible for nomination, as are investigators who have not applied for Ks and hope to use a KTGF fellowship as a stepping stone to a K award or other funding.
The Foundation accepts nominations only from the Chair of Departments of Psychiatry.
Each medical institution must select only one research project and investigator for nomination per fellowship.
|
|
|---|
|
ENHANCING DIVERSITY
IN ALCOHOL RESEARCH |
|
Drs. Flanagan, Back, and Squeglia are pleased to announce that applications are currently being accepted for the inaugural cohort of the Enhancing Diversity in Alcohol Research (EDAR) training program! This two-year, fully virtual, NIAAA-sponsored training program is open to psychology doctoral trainees from underrepresented backgrounds (per NIH NOT-OD-20-031). No prior alcohol research experience is required!
|
|
|
|
|
More details are available in our EDAR Program Brochure. Please also contact Dr. Julianne Flanagan (Director) or Ms. Jocelyn Rogers (Coordinator) with questions.
Applications are due July 31, 2021 and include a brief online survey, a 1-2 page statement of interest, and current CV: Click here to apply to EDAR
***Attention Faculty: Please contact us if you are interested
in becoming a prospective EDAR mentor!***
|
|
|---|
|
LOWCOUNTRY
MENTAL HEALTH CONFERENCE |
|
OUT OF THE DARKNESS
CHARLESTON AREA WALK |
|
Join the MUSC Psychiatry Team at the American Foundation for Suicide Prevention Out of the Darkness Charleston Area Walk! This year’s department goal is 25 participants and $5,000 (that’s $200 fundraising each!).
Date: 10/24/2021
Location: Riverfront Park
Registration: 1:00 pm
Event Time: 2:00 pm - 3:00 pm
To register for fundraising and participation: https://afsp.donordrive.com/team/270066
Questions? Email Meg Wallace at wallam@musc.edu
|
|
|---|
|
SELF CARE SUPPORT SESSIONS |
|
COMPREHENSIVE PSYCHIATRIC
CARE SPECIALISTS (CPCS) |
|
The CPCS office is currently taking referrals for youth and adults for outpatient therapy and/or medication management. The CPCS office is located at 26 Bee Street and is seeing patients either virtually or in the office. All patients are self-pay at the time of the appointment and will be provided with the necessary paperwork to submit for reimbursement from their insurance companies. All department of psychiatry faculty members are eligible to see private patients in CPCS.
To make a referral or schedule an appointment, call 843-792-9396.
For more information about making a referral or joining the practice, feel free to contact Hilary Bernstein, LISW, DHA at bernsteh@musc.edu
Check out our website: Psychiatriccarespecialists.com
Like our Facebook page: Comprehensive Psychiatric Care Specialists
|
|
PRESIDENT'S VALUES IN ACTION AWARD |
|
The Medical University of South Carolina's values are the heart of the institution and each day these values are exhibited by employees who help to fulfill MUSC's vision statement, leading Health Innovation for the Lives We Touch.
Each year, the President's Values in Action award recognizes five deserving employees who demonstrate MUSC's five values: compassion, respect, innovation, collaboration, and integrity.
Award Submission Process
- Fill Out the Nomination Form
- Nomination information must include:
- Sponsor Name, Email, Department
- Nominee Name, Email, Department
- Value Demonstrated: Compassion / Respect / Innovation / Collaboration / Integrity
- A letter of recommendation from the sponsor, addressed to President Cole, explaining why the nominee is worthy of the award.
- The deadline for nominations is October 19, 2021.
- Nominees will be notified upon receipt of nomination. Sponsors will be copied on this notification as well. All nominees receive a certificate of nomination; sponsors of the five individuals selected for awards will receive a separate notification and details about award presentations in early November 2021.
- Winners will be chosen by President Cole based on the award criteria outlined below:
- Nominations are submitted to recognize an individual who has demonstrated one of the five institutional values within the course of the current calendar year between February and September 2021. Only five winners will be chosen during this time; one winner per MUSC value.
- Nominees can be submitted from any department across the MUSC enterprise, including the MUSC Regional Health Network.
- Nominations for individuals will be accepted. Self-nominations and team nominations will not be accepted.
- Diversity, equity and inclusion is a priority for the criteria of the Values in Action award, as the aim is to offer an award and recognition opportunity to all department and team members. This will provide an inclusive opportunity to recognize values that are demonstrated from a variety of backgrounds and skill sets.
Questions
For specific questions regarding the Values in Action award, please contact Heather Woolwine.
|
|
Addiction Sciences Division
Open Rank/Assistant Professor (UNIV, Full-Time): The successful applicant for this position will have either an MD or a PhD degree and will be expected to have an established and independent research program that will interface with the multidisciplinary NIAAA P50 Charleston Alcohol Research Center at MUSC.
Open Rank/Professor (UNIV, Full-Time): The successful applicant for this position will have either an MD or a PhD degree and will be expected to have an established and independent research program that will interface with the multidisciplinary NIAAA P50 Charleston Alcohol Research Center at MUSC.
|
|
|---|
|
FENTANYL URINE TEST
CLINICAL NEUROBIOLOGY LAB |
|
FENTANYL URINE TEST NOW OFFERED BY
THE CLINICAL NEUROBIOLOGY LAB (CNL)
The use of the powerful opiate drug, FENTANYL is on the rise, accounting for a large share of overdose deaths in SC, and the greater US.
Previously, urine drug testing at MUSC could not detect Fentanyl use. The Clinical Neurobiology Laboratory has recently completed an extensive validation of a qualitative (positive vs negative) urine test for the presence of Fentanyl which can be used to distinguish this drug from other commonly used/abused opiates such as oxycodone, buprenorphine and morphine. This test should aid clinicians in the evaluation of patients in multiple clinical settings, especially when illicit drug use is suspected.
Simply order: “Fentanyl, Urine, Qual (IOP LAB)” or “LAB9066”
|
|
|
|
|
Program for Researchers Affected by Pandemic
COVID-19 Voucher Program
The College of Medicine, Hollings Cancer Center, and South Carolina Clinical & Translational Research Institute (SCTR) are pleased to offer a new funding opportunity open to all MUSC tenured and tenure track faculty members whose research has been impacted by the COVID-19 pandemic. Funding of up to $2,000 is available to help investigators gather preliminary data for inclusion in a grant proposal by covering the cost of supplies and/or core and laboratory services; pay for publication costs; or develop a translational focus to their research. Vouchers cannot be used to fund computer purchases, PI or staff salary, or travel. These funds will be distributed through SCTR. A total of $200,000 is available to support these awards.
Who is eligible?
To be eligible to receive a voucher an individual must be a tenured or tenure-track faculty member and serve as PI on an active research grant. A faculty member can receive only one COVID voucher.
Apply
To apply for a voucher, select the COVID-19 Voucher Program in SPARCRequest. Awards will be made on a rolling basis until all funds are expended.
|
|
|---|
|
COVID VACCINE CALL CENTER |
|
Individuals needing to contact the MUSC COVID Vaccine Call Center can utilize the information below:
|
|
|---|
|
The COVID-19 Vaccine Task Force will be posting updates on the COVID-19 Vaccine intranet site, including information about the vaccine safety and efficacy, so our care team members can make an informed decision.
**Updated University Directives can be found here.**
|
|
|---|
|
LAB & TESTING OPTIONS
The following resource provides MUSC Health lab and testing options pertaining to COVID-19. Included on this page is information regarding drive-thru and “pop-up” mobile COVID testing locations, antibody or serology tests, drive-in lab and nurse visits, and original/classic lab testing.
MUSC Health Lab & Testing Options
|
|
|
MANDATORY SELF-MONITORING
Due to the activity of COVID-19 within the hospital and community, all employees, residents, fellows and students within all MUSC entities are directed to begin daily self-monitoring for COVID-19 symptoms. This applies regardless of whether you have been working remotely on a full-time or intermittent basis.
You need to continue daily self-monitoring, even if symptoms are not present.
|
|
|---|
|
UPDATES VIA THE HORSESHOE
In addition to updates provided by MUSC Enterprise, the Department of Psychiatry and Behavioral Sciences will also provide updates through our employee intranet, The Horseshoe. Updates will be provided regularly as new information becomes available. For your convenience, direct links are provided below.
|
|
|---|
|
NEUROCOVID RECOVERY & REHAB RESEARCH STUDY RECRUITMENT |
|
Testing a Wearable Telemedicine-controllable
taVNS Device for NeuroCovid Recovery and Rehab
Researcher: Mark George, M.D.
PRO Number: pro00101270
The purpose of the research is to test out a new form of treatment where we stimulate a nerve in your ear. This is called transcutaneous (through the skin) auricular (ear) vagus nerve stimulation (taVNS) which means that you will receive stimulation through the ear. The taVNS device looks like an ear bud you would use with your smart phone or computer. We are investigating whether or not taVNS can treat neurologic symptoms of COVID-19 which are termed NEUROCOVID. Some symptoms you may experience are new onset anxiety, depression, vertigo, loss of smell, headaches, fatigue, irritability, etc. This study is entirely online and all assessments will be completed virtually.
Recruitment Contact
Sarah Huffman
843-876-5141
huffmans@musc.edu
|
|
|
|
|
COVID-19 RESILIENCY CLINIC |
|
NAMI CONNECTION & NAMI FAMILY SUPPORT |
|
UPDATED MOONLIGHTING POLICY |
|
THANK YOU TO OUR SUPPORTERS |
|
If you would like to submit content to include in next week's Chair Update, please submit to Dr. Jamie Fisher by 12:00 pm on Monday. Thank you. |
|
|---|
|
|
|
| | |
|  |
|
|
|
|
